Desensitization and recovery of PGE2-responsive ovarian adenylate cyclase modulated by agents affecting cytoskeletal function.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D003571:Cytochalasin B / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects*; D003599:Cytoskeleton / Q000187:drug effects*; D003903:Deuterium / Q000494:pharmacology; D005260:Female; D007158:Immunologic Techniques; D008094:Lithium / Q000494:pharmacology; D008870:Microtubules / Q000187:drug effects*; D015879:Myosin Subfragments / Q000494:pharmacology; D010590:Phalloidine / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011982:Receptors, Prostaglandin / Q000187:drug effects*
D015879:Myosin Subfragments; D011458:Prostaglandins E; D011956:Receptors, Cell Surface; D011982:Receptors, Prostaglandin; D010590:Phalloidine; D003571:Cytochalasin B; D008094:Lithium; D003903:Deuterium; D000242:Cyclic AMP; D000262:Adenylyl Cyclases